COVID-19

News

Roche axes two pipeline COVID drugs as pandemic hits Q1 phar...

Roche has axed two mid-stage COVID drugs from its development pipeline, according to a first quarter results statement showing the pandemic has hit sales in its medicines business.

News

EU safety regulators clear J&J COVID shot despite tiny clot ...

The benefits of Johnson & Johnson’s COVID-19 vaccine outweigh a tiny risk of unusual blood clots forming, Europe’s drugs regulator has said.

News

EU orders another 100m doses of Pfizer/BioNTech COVID jab

The EU has continued a refocus of its COVID-19 vaccination drive on mRNA shots, ordering another 100 million doses of Pfizer and BioNTech's Comirnaty shot.

News

scientifically visualization of a coronavirus spike protein

EMA starts review of GSK/Vir COVID-19 antibody

The EMA has started reviewing the emergency use application for GlaxoSmithKline and Vir Biotech's COVID-19 antibody VIR-7831, which could become the fourth drug of its type cleared for earl

News

Risk of brain clots higher with COVID than vaccine, study su...

A study has suggested that the risk of getting a serious brain clot is eight to 10 times higher in people with COVID-19 than those who get a vaccine.

News

Czech Republic swoops for Denmark's 2.4m unwanted AZ COVID s...

The Czech Republic wants to buy around 2.4 million doses of the AstraZeneca/Oxford University vaccine ditched by Denmark, which has said it will stop using it because of concerns about rare

Roche axes two pipeline COVID drugs as pandemic hits Q1 phar...

EU safety regulators clear J&J COVID shot despite tiny clot ...

EU orders another 100m doses of Pfizer/BioNTech COVID jab

EMA starts review of GSK/Vir COVID-19 antibody

Risk of brain clots higher with COVID than vaccine, study su...

Czech Republic swoops for Denmark's 2.4m unwanted AZ COVID s...

Otsuka grows in neuroplastogens with $1.225bn Transcend buy

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks